Biocept is a cancer diagnostics company with efforts focused on developing and commercializing proprietary circulating tumor cell and DNA tests using a standard blood sample. BIOC tests deliver information to oncologists that enable them to choose the best possible treatment for their patients based on tumor data characteristics. Headquartered in San Diego, California, the company was founded in 1997.  For more information, visit the company’s website at www.biocept.com